ASND Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ascendis Pharma A/S

Watchlist Manager

Watchlist

Price: 263.59 USD 0.9% Market Closed

Market Cap: $16.4B

	Ascendis Pharma A/S NASDAQ:ASND	DK
	Luca Mining Corp XTSX:LUCA	CA
V	Volcano Bhd KLSE:VOLCANO	MY
	Doximity Inc NYSE:DOCS	US
F	First Class Metals PLC LSE:FCM	UK
	El En SpA F:EE5	IT
	Ampeak Energy Ltd LSE:AMP	UK
P	Pepkor Holdings Ltd JSE:PPH	ZA
	China Railway Group Ltd SSE:601390	CN
B	Baxter International Inc BMV:BAX	US
	Obrascon Huarte Lain SA MAD:OHLA	ES
	Omnicell Inc NASDAQ:OMCL	US
T	Toray Industries Inc OTC:TRYIY	JP
B	Biome Australia Ltd ASX:BIO	AU

Profitability Summary

Ascendis Pharma A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

91%

Strong 3Y Average Gross Margin

86%

Gross Margin is Increasing

80% > 91%

Healthy Operating Margin

25%

Negative 3Y Average Operating Margin

-91%

Operating Margin is Increasing

-484% > 25%

Exceptional Net Margin

71%

Negative 3Y Average Net Margin

-100%

Net Margin is Increasing

-511% > 71%

Exceptional Free Cash Flow Margin

32%

Negative 3Y Average Free Cash Flow Margin

-85%

Free Cash Flow Margin is Increasing

-461% > 32%

Exceptional ROE

119%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-60%

ROIC is Increasing

-205% > 216%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.